Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GEDmatch is a consumer genetic genealogy and DNA comparison platform that lets users upload autosomal DNA files from major direct-to-consumer testing services and compare them across a large cross-platform database. The service provides genealogy-focused analysis tools such as one-to-many matching, one-to-one comparisons, admixture/ancestry utilities, clustering, and family-tree research features. Founded in 2010 by Curtis Rogers and John Olson, GEDmatch was acquired by Verogen in December 2019 and now sits within the QIAGEN/Verogen human identification and forensics portfolio. In addition to its consumer genealogy site, the broader business includes GEDmatch PRO, a forensic investigative genetic genealogy offering used by law-enforcement and forensic investigators. Although genomics-related, GEDmatch is not a therapeutic biotech or pharma company and does not operate a drug development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GEDmatch.